Establishment and Characterization of a Bladder Cancer Cell Line With Enhanced Doxorubicin Resistance by Mevalonate Pathway Activation
Tumor Biology - United States
doi 10.1007/s13277-014-2959-9
Full Text
Open PDFAbstract
Available in full text
Date
January 8, 2015
Authors
Publisher
Springer Science and Business Media LLC